Cost-effectiveness of temozolomide for the threatment of newly diagnosed glioblastoma multiforme

Carin Uyl - de Groot, R Stupp, Martin van den Bent

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	235-241
Number of pages	7
Journal	Expert review of pharmacoeconomics & outcomes research
Volume	9
Issue number	3
DOIs	https://doi.org/10.1586/erp.09.15
Publication status	Published - 2009

Research programs

@article{ca3cad38dacb4e1b9c16d429bc32c713,

title = "Cost-effectiveness of temozolomide for the threatment of newly diagnosed glioblastoma multiforme",

author = "{Uyl - de Groot}, Carin and R Stupp and {van den Bent}, Martin",

year = "2009",

doi = "10.1586/erp.09.15",

language = "Undefined/Unknown",

volume = "9",

pages = "235--241",

journal = "Expert review of pharmacoeconomics & outcomes research",

issn = "1473-7167",

publisher = "Taylor & Francis Ltd",

number = "3",

}

TY - JOUR

T1 - Cost-effectiveness of temozolomide for the threatment of newly diagnosed glioblastoma multiforme

AU - Uyl - de Groot, Carin

AU - Stupp, R

AU - van den Bent, Martin

PY - 2009

Y1 - 2009

U2 - 10.1586/erp.09.15

DO - 10.1586/erp.09.15

M3 - Article

C2 - 19527095

SN - 1473-7167

VL - 9

SP - 235

EP - 241

JO - Expert review of pharmacoeconomics & outcomes research

JF - Expert review of pharmacoeconomics & outcomes research

IS - 3

ER -